Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer

The purpose of this study is to provide high quality oncology services to patients with inoperable Non-Small Cell Lung Cancer (NSCLC) in Greece. These services will be based on 3 pillars: 1. Clinical: personalized treatment will be administered and its effectiveness and safety will be recorded and evaluated. 2. Molecular: the gene footprint of each patient at the beginning of his treatment, the molecular identity of his tumor will be analyzed and recorded based on analysis with modern Next Generation Sequencing (NGS) techniques. 3. Digital: Patients will have access to the digital platform where they will record the adverse reactions they will face during their treatment.

Inclusion Criteria: * Patients with non-small cell lung cancer stage IV * No younger than 18 years old patients * Performance status: 0-2 * Existence of biological material for the molecular analysis * Patients who have not been treated with any other treatment than adjuvant * Ability to use a mobile device or computer for digital communication Exclusion Criteria: * Childbearing women * Patients with PS \> 3 * Limited ability to use a mobile device for basic digital communication